Sodium Phosphates Injection USP 268 mg

Sodium Phosphates Injection USP 268 mg is a sterile solution used for intravenous administration. It contains sodium phosphate dibasic and is manufactured by Sandoz Canada Incorporated. This medication is commonly used to replenish phosphate levels in the body.

Sodium Phosphates Injection USP 268 mg is primarily used to treat phosphate deficiency, which can occur due to various medical conditions or treatments. It helps to restore and maintain adequate phosphate levels in the body, supporting essential bodily functions. This solution is administered intravenously to ensure quick absorption and effectiveness.

Common effects of Sodium Phosphates Injection USP 268 mg may include temporary discomfort at the injection site. Some individuals might experience mild symptoms such as nausea or headache. These effects are generally short-lived and should be monitored by a healthcare professional.

Sodium Phosphates Injection USP 268 mg should be handled with care to avoid contamination. It is important to follow proper storage guidelines and use sterile equipment for administration. Patients with known allergies to phosphate compounds should consult their healthcare provider before use.

Sodium Phosphates Injection USP 268 mg may interact with certain medications, including those that affect electrolyte balance. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of this injection.